Cargando…

The Microbiome and its Impact on Disease in the Preterm Patient

Emerging technologies derived largely from the Human Genome Project are applied to evaluating the intestinal microbiota in preterm infants. The microbial ecology of the developing intestine is highly related to health and disease, and new discoveries are emerging that will help us understand disorde...

Descripción completa

Detalles Bibliográficos
Autor principal: Neu, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240619/
https://www.ncbi.nlm.nih.gov/pubmed/25422793
http://dx.doi.org/10.1007/s40124-013-0031-7
_version_ 1782345744821256192
author Neu, Josef
author_facet Neu, Josef
author_sort Neu, Josef
collection PubMed
description Emerging technologies derived largely from the Human Genome Project are applied to evaluating the intestinal microbiota in preterm infants. The microbial ecology of the developing intestine is highly related to health and disease, and new discoveries are emerging that will help us understand disorders in the development of the intestinal microbial ecosystem and how to eventually manipulate them to prevent diseases such as necrotizing enterocolitis and late onset sepsis. Here, a brief overview of the developing microbiome as it pertains to several aspects of health and disease in the preterm infant is presented.
format Online
Article
Text
id pubmed-4240619
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-42406192014-12-01 The Microbiome and its Impact on Disease in the Preterm Patient Neu, Josef Curr Pediatr Rep Neonatology (FR Greer, Section Editor) Emerging technologies derived largely from the Human Genome Project are applied to evaluating the intestinal microbiota in preterm infants. The microbial ecology of the developing intestine is highly related to health and disease, and new discoveries are emerging that will help us understand disorders in the development of the intestinal microbial ecosystem and how to eventually manipulate them to prevent diseases such as necrotizing enterocolitis and late onset sepsis. Here, a brief overview of the developing microbiome as it pertains to several aspects of health and disease in the preterm infant is presented. Springer US 2013-10-01 2013 /pmc/articles/PMC4240619/ /pubmed/25422793 http://dx.doi.org/10.1007/s40124-013-0031-7 Text en © Springer Science + Business Media New York 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Neonatology (FR Greer, Section Editor)
Neu, Josef
The Microbiome and its Impact on Disease in the Preterm Patient
title The Microbiome and its Impact on Disease in the Preterm Patient
title_full The Microbiome and its Impact on Disease in the Preterm Patient
title_fullStr The Microbiome and its Impact on Disease in the Preterm Patient
title_full_unstemmed The Microbiome and its Impact on Disease in the Preterm Patient
title_short The Microbiome and its Impact on Disease in the Preterm Patient
title_sort microbiome and its impact on disease in the preterm patient
topic Neonatology (FR Greer, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240619/
https://www.ncbi.nlm.nih.gov/pubmed/25422793
http://dx.doi.org/10.1007/s40124-013-0031-7
work_keys_str_mv AT neujosef themicrobiomeanditsimpactondiseaseinthepretermpatient
AT neujosef microbiomeanditsimpactondiseaseinthepretermpatient